Necrotising leucoencephalopathy associated with intrathecal/intraventricular methotrexate therapy.
D000293:Adolescent; D000328:Adult; D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D007276:Injections, Intraventricular; D007278:Injections, Spinal; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D008297:Male; D008577:Meningeal Neoplasms / Q000628:therapy; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D009336:Necrosis
D008727:Methotrexate